Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > TX Providers > Neurologists

Dr. Mehari Gebreyohanns, MD

(No ratings)

Specializes in: Neurology (Brain & Spinal Cord Disease)

Morehouse School of Medicine (1995 - 1999)

Professional interests include: stroke, cerebrovascular disease, neurocritical care

5303 Harry Hines Boulevard 7th Floor Suite 600
Dallas, TX 75390

(214) 645-8800

Dr. Mehari Gebreyohanns, MD is a neurologist in Dallas, TX specializing in neurology (brain & spinal cord disease). He graduated from Morehouse School of Medicine in 1999 and has 25 years of experience. Dr. Mehari Gebreyohanns, MD is affiliated with Texas Health Resources and UT Southwestern Medical Center.

Office Locations

Address:

5303 Harry Hines Boulevard 7th Floor Suite 600
Dallas, TX 75390

Some issues Dr. Mehari Gebreyohanns, MD can help you with:

Stroke

A stroke is a medical emergency that occurs when a blood vessel supplying oxygen and nutrients to the brain is ruptured or blocked. The brain cannot function without a steady supply of oxygen and nutrients, so when the blood supply to the brain is interrupted, even for a brief moment, brain cells begin to die. When a sufficient number of brain cells die, the brain itself can no longer function, meaning that strokes are very dangerous. Strokes can result in impaired movement, speech, cognitive ability, the impairment of important physical functions, and even death.

Anyone can have a stroke, regardless of age and health. Strokes are known to happen at random. However, certain conditions and behaviors can increase one's risk of stroke over time.

Risk factors for stroke include:

Heart disease
Older age
Smoking
Diabetes
High blood pressure
High blood cholesterol and lipids

There are two main types of stroke: ischemic stroke and hemorrhagic stroke. Ischemic stroke occurs more commonly and is when a blood vessel in the brain becomes blocked. Blockages are caused by blood clots and built-up plaque (deposits of fat and cholesterol), which leads to atherosclerosis, a condition where the blood vessels narrow and harden. The resultant restricted blood flow may lead to an ischemic stroke by blocking essential oxygen to the brain, causing the heart to exert more effort to pump blood.

Hemorrhagic stroke occurs when a blood vessel in or around the brain ruptures. The burst vessel leaks blood into surrounding brain tissue, causing irreparable brain damage.

Hemorrhagic strokes are less common and may occur from head injuries, brain aneurysms, brain tumors, and bleeding disorders, amongst other conditions.

Both ischemic and hemorrhagic strokes require immediate medical treatment. Medical intervention can prevent severe and life-threatening brain damage. Signs of stroke include:

-Disorientation or confusion

-Difficulty speaking

-Difficulty walking

-Impaired vision

-Weakness in the face, legs, or arms

-Severe headaches

When someone suspected of having a stroke reaches the hospital, the patient will usually receive a CT or other scan that provides an image of the brain. The scan results can reveal clotted or leaking blood in the brain. Physical exams, neurological exams, and blood tests may also be used to check for blood clotting and sugar. Treatment begins generally immediately if a stroke is detected.

Medical treatment for ischemic strokes includes a thrombolytic medicine which breaks up and disperses blood clots. This medicine can greatly improve stroke recovery and long-term health. However, the thrombolytic medicine must be administered as soon as possible to achieve these results. Other treatments for ischemic strokes are blood thinners and thrombectomy, a surgical procedure to remove a blood clot in the brain. Thrombectomy is performed by inserting a catheter (thin needle) into the artery to reach the blood clot and mechanically remove it. With the clot removed, normal blood flow to the brain resumes. Thrombectomy is typically performed at most six hours after a patient shows signs of a stroke.

Hemorrhagic strokes are treated with blood-saving medication and surgery. For a hemorrhagic stroke caused by the rupture of an aneurysm (blood vessel bulges), surgery to stem the bleeding aneurysm and vessel may be used. One surgical technique is stent-assisted coiling, which adds a stent (small wire-meshed tube) into the blood vessel to block the leaking opening of the aneurysm. A non-surgical procedure is endovascular coiling, where a catheter (thin, hollow needle) places a platinum wire coil at the spot of the aneurysm. The coil blocks bleeding and prevents the aneurysm from continuing to leak blood. These procedures are usually combined with blood-thickening medications. Blood transfusions may be administered if substantial blood loss has occurred.

Since stroke patients may have lost some essential functions while the blood flow to their brains was obstructed, both ischemic stroke and hemorrhage stroke patients may receive post-stroke rehabilitation to rebuild their physical and mental abilities. Some restorative treatments include occupational, physical, and speech therapy. Patients may also receive care from neurologists, who can assist patients in recovering certain brain functions and cognitive abilities, and rehabilitation psychologists, who may help patients with their emotional, behavioral, and cognitive recovery. Some stroke patients require lengthy rehabilitation and may never fully regain function, while others may recover more quickly. While the fastest recovery improvements are usually seen in the first three or four months, stroke rehabilitation can last for years.

If someone begins to show signs of stroke, contact emergency services and call 9-1-1 immediately since blood flow must be restored as soon as possible to help avoid significant brain damage. If an ambulance takes the person to the hospital, paramedics can initiate stroke treatment as soon as the patient enters the ambulance, allowing for more prompt medical intervention and care.

In The News

“Dr. Mehari Gebreyohanns, a UT Southwestern neurologist, coined a term for "stroke" in Amharic, a language spoken by native Ethiopians.”—"Ethiopians didn't have a term for 'stroke,' so this Dallas doctor created one", Dallas News, March 2019

hospital care	424
inpatient care	424

**Gender**
Male	76
Female	77

**Ethnicity**
Non-Hispanic White	74
Black	52
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	51
From 75 to 84	35
85 and over	15
Less than 65	52

Hypertension	75
High Cholesterol	75
Stroke	63
Ischemic Heart Disease	52
Depression	52
Chronic Kidney Disease	56
Asthma	14
Osteoperosis	12
Atrial Fibrilation	23
Heart Failure	46
Chronic Obstructive Pulmonary Disease	22
Diabetes	54
Dementia	31
Cancer	15

hospital care	298
inpatient care	298

**Gender**
Male	44
Female	64

**Ethnicity**
Non-Hispanic White	49
Black	37
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	32
From 75 to 84	32
85 and over	14
Less than 65	30

Hypertension	75
High Cholesterol	75
Stroke	70
Ischemic Heart Disease	49
Depression	49
Chronic Kidney Disease	55
Asthma	11
Osteoperosis	16
Atrial Fibrilation	17
Heart Failure	43
Chronic Obstructive Pulmonary Disease	25
Diabetes	51
Dementia	34
Cancer	18

hospital care	363
inpatient care	363

**Gender**
Male	136
Female	120

**Ethnicity**
Non-Hispanic White	132
Black	86
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	90
From 75 to 84	74
85 and over	32
Less than 65	60

Hypertension	75
High Cholesterol	75
Stroke	75
Ischemic Heart Disease	54
Depression	50
Chronic Kidney Disease	59
Asthma	18
Osteoperosis	11
Atrial Fibrilation	23
Heart Failure	45
Chronic Obstructive Pulmonary Disease	19
Diabetes	46
Dementia	29
Cancer	13

hospital care	504
inpatient care	504

**Gender**
Male	84
Female	85

**Ethnicity**
Non-Hispanic White	105
Black	43
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	75
From 75 to 84	50
85 and over	25
Less than 65	19

Hypertension	75
High Cholesterol	75
Stroke	75
Ischemic Heart Disease	65
Depression	42
Chronic Kidney Disease	65
Asthma	28
Osteoperosis	10
Atrial Fibrilation	34
Heart Failure	49
Chronic Obstructive Pulmonary Disease	27
Diabetes	50
Dementia	39
Cancer	13

hospital care	381
inpatient care	381

**Gender**
Male	71
Female	75

**Ethnicity**
Non-Hispanic White	92
Black	40
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	51
From 75 to 84	56
85 and over	20
Less than 65	19

Hypertension	75
High Cholesterol	75
Stroke	75
Ischemic Heart Disease	68
Depression	47
Chronic Kidney Disease	71
Asthma	14
Osteoperosis	16
Atrial Fibrilation	24
Heart Failure	47
Chronic Obstructive Pulmonary Disease	31
Diabetes	52
Dementia	42
Cancer	22

hospital care	358
inpatient care	358

**Gender**
Male	62
Female	60

**Ethnicity**
Non-Hispanic White	71
Black	28
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	45
From 75 to 84	42
85 and over	24
Less than 65	11

Hypertension	75
High Cholesterol	75
Stroke	75
Ischemic Heart Disease	61
Depression	48
Chronic Kidney Disease	69
Asthma	11
Osteoperosis	15
Atrial Fibrilation	28
Heart Failure	49
Chronic Obstructive Pulmonary Disease	26
Diabetes	50
Dementia	50
Cancer	19

hospital care	272
inpatient care	272

**Gender**
Male	55
Female	65

**Ethnicity**
Non-Hispanic White	0
Black	32
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	41
From 75 to 84	33
85 and over	23
Less than 65	23

Hypertension	75
High Cholesterol	75
Stroke	75
Ischemic Heart Disease	65
Depression	47
Chronic Kidney Disease	0
Asthma	11
Osteoperosis	19
Atrial Fibrilation	33
Heart Failure	48
Chronic Obstructive Pulmonary Disease	26
Diabetes	52
Dementia	0
Cancer	20

hospital care	266
inpatient care	266

**Gender**
Male	59
Female	56

**Ethnicity**
Non-Hispanic White	62
Black	28
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	48
From 75 to 84	25
85 and over	19
Less than 65	23

Hypertension	75
High Cholesterol	75
Stroke	75
Ischemic Heart Disease	61
Depression	42
Chronic Kidney Disease	71
Asthma	0
Osteoperosis	10
Atrial Fibrilation	25
Heart Failure	49
Chronic Obstructive Pulmonary Disease	25
Diabetes	59
Dementia	46
Cancer	17

hospital care	601
inpatient care	601

Average Medicare Procedure Volume From 2013 - 2021

Volume of procedures performed by Dr. Mehari Gebreyohanns, MD for Medicare patients.

The highest averages for the top procedures that Dr. Mehari Gebreyohanns, MD treated as a neurologist in Dallas, TX were hospital care and inpatient care.

hospital care	385
inpatient care	385

Average Medicare Patient Data From 2013 - 2021

Information about Medicare patients treated by Dr. Mehari Gebreyohanns, MD.

**Gender**
Male	58
Female	60

**Ethnicity**
Black / African American	34
Asian / Pacific Islander	0
Non-Hispanic White	58
Native American / Alaskan Native	0
Hispanic	0
Other	0

**Age**
75 to 84	34
85 and over	17
Less than 65	23
65 to 74	43

Average of Total of Conditions of Medicare patients treated by Dr. Mehari Gebreyohanns, MD From 2013 - 2021

The highest averages of the most common conditions of Medicare patients that Dr. Mehari Gebreyohanns, MD treated were high cholesterol, hypertension, stroke and ischemic heart disease.

Hypertension	60
High Cholesterol	60
Stroke	58
Ischemic Heart Disease	47
Depression	37
Chronic Kidney Disease	44
Asthma	10
Osteoporosis	10
Heart Failure	37
Chronic Obstructive Pulmonary Disease	20
Diabetes	41
Atrial Fibrillation	20
Cancer	13
Dementia	27

Education & Training

Dr. Mehari Gebreyohanns, MD graduated from Morehouse School of Medicine in 1999. He completed residency at Atlanta Medical Center. He has a state license in Texas.

Medical School: Morehouse School of Medicine (1999)

Residency: Atlanta Medical Center (2001)

Licensed In: Texas

Affiliations & Hospitals

Dr. Mehari Gebreyohanns, MD is associated with these hospitals and organizations:

Texas Health Resources

UT Southwestern Medical Center

Ratings & Reviews

Dr. Mehari Gebreyohanns, MD does not have any reviews yet, be the first to leave a review of Dr. Mehari Gebreyohanns, MD here: Leave a Review

(No ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. Mehari Gebreyohanns, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
AstraZeneca Pharmaceuticals LP	$1,615 BRILINTA $1,615
UCB, Inc.	$218 Vimpat $112	Briviact $105
Rapid Medical LTD	$142 COMANECI 17 $142
Stryker Corporation	$140 STENTRIEVERS $140
Acorda Therapeutics, Inc	$116 AMPYRA $116
Other	$79 APTIOM $79

**Types of Payments**
Travel and Lodging	$1,321
Food and Beverage	$988

Research Payments

Dr. Mehari Gebreyohanns, MD has received 5 research payments totaling $26,657.

Biography

Dr. Mehari Gebreyohanns is a Dallas, TX physician who specializes in neurology (brain & spinal cord disease). His areas of expertise include stroke and neurocritical care. His professional affiliations include Texas Health Resources and UT Southwestern Medical Center. After attending Morehouse School of Medicine, Dr. Gebreyohanns completed his residency training at Atlanta Medical Center.